Professor Gerd Gigerenzer of the Max Planck Institute for Human Development in Berlin is one of the world’s leaders in risk communication. He teaches doctors, policy-makers, journalists and the general public.
He has written before about how misleading communication of risk is a moral issue for medical journals, for journalists, for researchers, and for anyone who communicates to the public about health care issues. For example, see his October editorial in the BMJ. Excerpt:
“In 1995, the UK Committee on Safety of Medicines issued a warning that third generation oral contraceptive pills increased the risk of potentially life threatening thrombosis twofold. The news provoked great anxiety, and many women stopped taking the pill, which led to unwanted pregnancies and abortions–some 13 000 additional abortions in the next year in England and Wales–and an extra £46m (55m; $71m) in costs for the NHS. Yet how big was the twofold risk? The studies revealed that for every 7000 women who took the earlier, second generation pills, one had a thrombosis, and this number increased to two in women who took third generation pills. The problem of misleading reporting has not gone away. In 2009, the BMJ published two articles on oral contraceptives and thrombosis; one made the absolute numbers transparent in the abstract, whereas the
other reported that “oral contraceptives increased the risk of venous thrombosis fivefold.”
These two examples illustrate a general point. Absolute risks (reductions and increases), such as from one to two in 7000, are transparent, while relative risks such as “twofold” provide incomplete and misleading risk information. Relative risks do not inform about the baseline risk–for example, whether twofold means from one to two or from 50 to 100 in 7000–and without this information, people overestimate benefits or harms. In the case of the pill scare, the losers were women, particularly adolescent girls, taxpayers, and the drug industry. Reporting relative risks without baseline risk is practised not only by journalists because big numbers make better headlines or by health organisations because they increase screening participation rates. The source seems to be medical journals, from which figures spread to press releases, health pamphlets, and the media.”
Last week, at the Salzburg Global Seminar, “The Greatest Untapped Resource in Healthcare? Informing and Involving Patients in Decisions about Their Medical Care,” Gigerenzer addressed the issue again. He framed misleading communication of risk as a barrier to shared decision-making.
Another note: e-patient Dave has posted another reflection on what he learned at the Salzburg Global Seminar, calling Jack Wennberg’s practice variation research “an essential e-patient awareness topic.”
Here’s a photo of the Schloss Leopoldskron, site of the seminar. You can learn more about the Schloss here.
Comments
Please note, comments are no longer published through this website. All previously made comments are still archived and available for viewing through select posts.
Comments are closed.
Our Comments Policy
But before leaving a comment, please review these notes about our policy.
You are responsible for any comments you leave on this site.
This site is primarily a forum for discussion about the quality (or lack thereof) in journalism or other media messages (advertising, marketing, public relations, medical journals, etc.) It is not intended to be a forum for definitive discussions about medicine or science.
We will delete comments that include personal attacks, unfounded allegations, unverified claims, product pitches, profanity or any from anyone who does not list a full name and a functioning email address. We will also end any thread of repetitive comments. We don”t give medical advice so we won”t respond to questions asking for it.
We don”t have sufficient staffing to contact each commenter who left such a message. If you have a question about why your comment was edited or removed, you can email us at feedback@healthnewsreview.org.
There has been a recent burst of attention to troubles with many comments left on science and science news/communication websites. Read “Online science comments: trolls, trash and treasure.”
The authors of the Retraction Watch comments policy urge commenters:
We”re also concerned about anonymous comments. We ask that all commenters leave their full name and provide an actual email address in case we feel we need to contact them. We may delete any comment left by someone who does not leave their name and a legitimate email address.
And, as noted, product pitches of any sort – pushing treatments, tests, products, procedures, physicians, medical centers, books, websites – are likely to be deleted. We don”t accept advertising on this site and are not going to give it away free.
The ability to leave comments expires after a certain period of time. So you may find that you’re unable to leave a comment on an article that is more than a few months old.
You might also like